Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder [NA]
A not-yet-recruiting clinical trial at University Hospital, Montpellier, exploring conceptualizing Borderline Personality Disorder as a Rela…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO) [NA]
This clinical trial update notes that the study 'BIPLUMINO' is currently recruiting. It investigates nursing care for bipolar disorder patie…
-
EMA approval · 2026-01-12EMA Authorised: Abilify (aripiprazole) — Otsuka Pharmaceutical Netherlands B.V.
The EMA authorised Abilify (aripiprazole) by Otsuka Pharmaceutical Netherlands B.V. for schizophrenia and bipolar disorder in the European U…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder [Phase 2]
Phase 2 trial update for ABBV-932 in adults with Bipolar I or Bipolar II disorder, assessing adverse events and changes in disease activity;…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study [NA]
A recruiting study from the University of Texas at Austin examining acute alcohol response in individuals with bipolar disorder using longit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet? [NA]
A completed clinical trial (NCT05268809) examined whether a very low-carbohydrate ketogenic diet could improve neural network instability in…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
This clinical trial update reviews the performance of QbMobile in aiding differential diagnosis for ADHD symptoms across multiple psychiatri…
-
FDA approval · 2026-01-08FDA Approved: LAMOTRIGINE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an original ANDA for lamotrigine from Torrent Pharmaceuticals Limited, authorizing a generic lamotrigine product for use in app…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic [NA]
This clinical trial update describes the Meta Care Clinic, a pragmatic metabolic care program for patients with severe mental illness, with …
-
EMA approval · 2026-01-07EMA Authorised: Olanzapine Viatris (previously Olanzapine Mylan) (olanzapine) — Viatris Limited
The EMA has authorised Olanzapine Viatris for schizophrenia and bipolar disorder; the marketing authorization holder is Viatris Limited.
-
FDA approval · 2026-01-07FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine (generic), indicating approval of a modification to an alr…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Suicidal Behavior in Patients Diagnosed With Bipolar Disorder [NA]
An Emory University clinical trial is recruiting to study suicidal behavior in patients with bipolar disorder, including those with co-occur…
-
FDA approval · 2026-01-06FDA Approved: OLANZAPINE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Olanzapine submitted by Strides Pharma Science Limited. This action approves a supplemental …
-
FDA approval · 2026-01-06FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olanzapine by Macleods Pharmaceuticals Limited, supporting a generic version of the drug.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness [NA]
ClinicalTrials.gov update indicates the study 'Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness' is …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder [Phase 4]
Phase 4 trial evaluating tachyphylaxis, tolerance, and withdrawal after treatment with intranasal dexmedetomidine (Igalmi) for agitation in …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Mindfulness Psychoeducation for Bipolar Disorder [NA]
A completed clinical trial evaluating mindfulness psychoeducation for individuals with bipolar disorder; results are not provided in the sni…
-
FDA approval · 2025-12-31FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Lamotrigine from Aurobindo Pharma Limited, authorizing the marketing of a generic Lamotrigine pr…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Examination of Glutamate and mGluR5 in Psychiatric Disorders [NA]
The Yale University–sponsored trial examining glutamate signaling and mGluR5 involvement in major depressive disorder, post-traumatic stress…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A Study of Pregnant and Postpartum Women With and Without Mood Disorders
Completed clinical trial NCT03615794 sponsored by Johns Hopkins University studying mood disorders in pregnant and postpartum women.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Exercise Therapy in Mental Disorders-study [NA]
A clinical trial at Haukeland University Hospital is currently recruiting to evaluate the effects of exercise therapy in individuals with sc…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life
A clinical trial update shows that Çankırı Karatekin University is recruiting for a study examining how schizophrenia and bipolar disorder a…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Feasibility of eLi12 [NA]
A feasibility study of the investigational drug eLi12 for bipolar disorder; the trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Taking Action for College Students [NA]
Temple University is recruiting for a clinical trial studying major depressive disorder, bipolar disorder, and schizophrenia.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Anticipating Depressive and Manic Episodes in Bipolar Disorders Using Vocal Biomarkers [NA]
A clinical trial update describing a study to anticipate depressive and manic episodes in bipolar disorder using vocal biomarkers; the trial…